Infinity Pharmaceuticals Stock (NASDAQ:INFI)
Previous Close
$0.02
52W Range
$0.01 - $1.30
50D Avg
$0.09
200D Avg
$0.26
Market Cap
$726.09K
Avg Vol (3M)
$3.98M
Beta
1.38
Div Yield
-
INFI Company Profile
Infinity Pharmaceuticals, Inc., a biopharmaceutical company, focuses on developing novel medicines for people with cancer. Its product candidate is IPI-549, an orally administered clinical-stage immuno-oncology product candidate that inhibits the enzyme phosphoinositide-3-kinase-gamma, which is in Phase 2 clinical trials for the treatment of metastatic triple negative breast cancer and urothelial cancer; and Phase 1/1b clinical trials for the treatment of solid tumors. The company has strategic alliances with Intellikine, Inc. to discover, develop, and commercialize pharmaceutical products targeting the delta and/or gamma isoforms of PI3K; Verastem, Inc. to research, develop, commercialize, and manufacture duvelisib and products containing duvelisib; and PellePharm, Inc. to develop and commercialize rights to its hedgehog inhibitor program, IPI-926, a clinical-stage product candidate, as well as collaboration agreements with Arcus Biosciences, Inc., F. Hoffmann-La Roche Ltd., and Bristol Myers Squibb Company. Infinity Pharmaceuticals, Inc. was incorporated in 1995 and is headquartered in Cambridge, Massachusetts.
INFI Performance
Peer Comparison
Ticker | Company |
---|---|
NUVB | Nuvation Bio Inc. |
NXTC | NextCure, Inc. |
EWTX | Edgewise Therapeutics, Inc. |
ERAS | Erasca, Inc. |
ADTX | Aditxt, Inc. |
CTMX | CytomX Therapeutics, Inc. |
REVB | Revelation Biosciences, Inc. |
GBIO | Generation Bio Co. |
SQZ | SQZ Biotechnologies Company |
DRMA | Dermata Therapeutics, Inc. |
KRON | Kronos Bio, Inc. |
CCCC | C4 Therapeutics, Inc. |
ELDN | Eledon Pharmaceuticals, Inc. |
ASMB | Assembly Biosciences, Inc. |
NRBO | NeuroBo Pharmaceuticals, Inc. |
TARA | Protara Therapeutics, Inc. |
UNCY | Unicycive Therapeutics, Inc. |
TRVI | Trevi Therapeutics, Inc. |
NLTX | Neurogene Inc. |
CMRX | Chimerix, Inc. |
LYRA | Lyra Therapeutics, Inc. |
TIL | Instil Bio, Inc. |